Futility Analyses in Alzheimer's Disease (AD) Clinical Trials: A Risky Business

被引：7

作者：

Aisen, P. S. ^{[1
]}

Raman, R. ^{[2
,3
]}

机构：

[1] Univ South Calif, ATRI, San Diego, CA USA

[2] Univ Southern Calif, Keck Sch Med, ATRI, Biostat, 9860 Mesa Rim Rd, San Diego, CA 92121 USA

[3] Univ Southern Calif, Keck Sch Med, ACTC, Biostat Unit, 9860 Mesa Rim Rd, San Diego, CA 92121 USA

来源：

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE | 2020年 / 7卷 / 03期

关键词：

D O I：

10.14283/jpad.2020.20

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：195 / 196

页数：2

相关论文

共 5 条

[1] Participation in clinical trials and long-term outcomes in Alzheimer's disease
Albert, SM
Sane, M
Marder, K
Jacobs, DM
Brandt, J
Albert, M
Stern, Y
[J]. NEUROLOGY, 1997, 49 (01) : 38 - 43
[2] Bayesian predictive approach to interim monitoring in clinical trials
Dmitrienko, A
Wang, MD
[J]. STATISTICS IN MEDICINE, 2006, 25 (13) : 2178 - 2195
[3] Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease
Galasko, Douglas
Bell, Joanne
Mancuso, Jessica Y.
Kupiec, James W.
Sabbagh, Marwan N.
van Dyck, Christopher
Thomas, Ronald G.
Aisen, Paul S.
[J]. NEUROLOGY, 2014, 82 (17) : 1536 - 1542
[4] A review of methods for futility stopping based on conditional power
Lachin, JM
[J]. STATISTICS IN MEDICINE, 2005, 24 (18) : 2747 - 2764
[5] MONITORING CLINICAL-TRIALS - CONDITIONAL OR PREDICTIVE POWER
SPIEGELHALTER, DJ
FREEDMAN, LS
BLACKBURN, PR
[J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (01): : 8 - 17